← Eichor
Study identifier: NCT06157346 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude

Condition: Health · Children, Only · Gut Microbiota  ·  Sponsor: Ruijin Hospital

PhaseN/A
Planned participants300
Who can joinAll sexes, 1 Year to 3 Years
Healthy volunteersYes

About this study

Microbes and the human body maintain a complex relationship of interaction and influence. Different regions, altitudes, and dietary habits have different degrees of influence on the composition of children's intestinal flora. Therefore, the development and maturation process of children's intestinal flora in plateau areas was discovered, and its relationship with children's immunity, metabolism, and growth was understood. The mechanism of action of children's intestinal flora on immunity, growth and development was further analyzed by comparing it with people in low-altitude areas, to provide a scientific basis for improving children's health in plateau areas.

This description comes directly from the study's public registry record.

Talk to the study team

Xinqiong Wang  ·  0086-021-64370045  ·  wxq11671@rjh.com.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06157346